Abstract
In medicinal chemistry, one of the most studied molecules in recent history is taxol. Taxol is a versatile natural product that is used in various cancer treatment regimens. It is administered to patients with breast, lung, and ovarian cancers, and is currently being studied for the treatment of squamous cell carcinoma of the oral cavity and tongue. Taxol has been tested in a number of research and clinical phase trials to determine feasibility, toxicity, and cytotoxicity against oral squamous cell carcinoma as a single drug regimen and as a contributing drug component in treatment plans. This paper reviews over forty articles that examine cell lines, murine models, and human results for the response of taxol against squamous cell carcinoma (SCC) of the oral cavity and the tongue.
Keywords: 5-fluorouracil (5-FU), cisplatin, carboplatin, hydroxyurea, hyaluronic acid oral squamous cell carcinoma (OSCC), oxaliplatin, paclitaxel, taxol, oral cancer, tongue cancer,
Mini-Reviews in Medicinal Chemistry
Title:Taxol: Efficacy Against Oral Squamous Cell Carcinoma
Volume: 13 Issue: 4
Author(s): Kaitlyn Ledwitch, Ryenne Ogburn, Jodi Cox, Rebekah Graham, Allison Fritzsche, Donna Gosnell and Thomas Manning
Affiliation:
Keywords: 5-fluorouracil (5-FU), cisplatin, carboplatin, hydroxyurea, hyaluronic acid oral squamous cell carcinoma (OSCC), oxaliplatin, paclitaxel, taxol, oral cancer, tongue cancer,
Abstract: In medicinal chemistry, one of the most studied molecules in recent history is taxol. Taxol is a versatile natural product that is used in various cancer treatment regimens. It is administered to patients with breast, lung, and ovarian cancers, and is currently being studied for the treatment of squamous cell carcinoma of the oral cavity and tongue. Taxol has been tested in a number of research and clinical phase trials to determine feasibility, toxicity, and cytotoxicity against oral squamous cell carcinoma as a single drug regimen and as a contributing drug component in treatment plans. This paper reviews over forty articles that examine cell lines, murine models, and human results for the response of taxol against squamous cell carcinoma (SCC) of the oral cavity and the tongue.
Export Options
About this article
Cite this article as:
Ledwitch Kaitlyn, Ogburn Ryenne, Cox Jodi, Graham Rebekah, Fritzsche Allison, Gosnell Donna and Manning Thomas, Taxol: Efficacy Against Oral Squamous Cell Carcinoma, Mini-Reviews in Medicinal Chemistry 2013; 13 (4) . https://dx.doi.org/10.2174/1389557511313040004
DOI https://dx.doi.org/10.2174/1389557511313040004 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation
Current Medicinal Chemistry PET-MRI Based Molecular Imaging as a Response Marker in Cervical Cancer: A Systematic Review
Current Molecular Imaging (Discontinued) Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Current Drug Targets Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers
Current Cancer Therapy Reviews Membrane Rafts in the Respiratory System
Current Respiratory Medicine Reviews Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design Anti-cancer Peptides from Ras-P21 and P53 Proteins
Current Pharmaceutical Design Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia
Current Gene Therapy Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies MicroRNA: Biogenesis, Function and Role in Cancer
Current Genomics The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Current Cancer Drug Targets The Coronin Family and Human Disease
Current Protein & Peptide Science microRNAs: Small Molecules with a Potentially Role in Oral Squamous Cell Carcinoma
Current Pharmaceutical Design Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations
Current Pharmaceutical Design Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency
Current Drug Targets Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry miRNAs as Modulators of Cholesterol in Breast Cancer Stem Cells: An Approach to Overcome Drug Resistance in Cancer
Current Drug Targets Drug Design Studies of the Novel Antitumor Targets Carbonic Anhydrase IX and XII
Current Medicinal Chemistry